Thursday, July 10, 2014

Optimizing Samples for Future Use: Innovative technology to improve the functional quality control of DNA samples

Biobanking is an exact science to say the least and requires a very technical approach.  Without a true, accepted set of best practices to go by, it becomes important to draw on the knowledge and experience of others.  Join us for a live one-hour webinar with Dr. Andrew Brooks, COO of RUCDR Infinite Biologics, and Dr. Tatiana Foroud, Director, Division of Hereditary Genomics and a P. Michael Conneally Professor of Medical and Molecular Genetics at Indiana University as they cover some of their latest experiences in the industry.

What you’ll learn
  •    - Reinforce the integrated, high-science approach to biobanking and bioprocessing services provided by the BioProcessing Solutions Alliance
  •    - Discuss the benefits of conducting DNA and RNA functional quality control analysis of samples to support improved storage and selection of samples for downstream analysis
  •    - Provide a research client perspective on the need for high-quality samples to support translational research
  •    - Provide examples of how functional quality control analysis of nucleic acids using SNPtrace™ technology has improved the selection of samples to support downstream applications
Date: Monday, 8/4
Time: 2:00 – 3:00 EST
Cost: FREE
Code: XP1998BLOG

About the speakers

Andrew Brooks, Ph.D.
As Chief Operating Officer of RUCDR Infinite Biologics, Dr. Andrew Brooks oversees the operations of laboratories within RUCDR, ensuring consistent and superior quality standards for all services.
Since joining RUCDR, he has worked to automate and develop the service infrastructure to provide high throughput sample management and analysis for DNA, RNA and protein-based technologies to hundreds of labs globally. His methodologies extend the use of valuable samples by extracting and renewing limited quantities of biomaterial with newly developed technologies.

Dr. Brooks is a well-recognized genomicist and has developed and implemented cutting-edge, molecular-based technologies for nucleic acid and protein analyses.  As a molecular neuroscientist, his research focuses on deciphering the molecular mechanisms underlying memory and learning.
Dr. Brooks is an Associate Professor of Genetics at Rutgers, The State University of New Jersey. He received his Ph.D. from the University of Rochester, School of Medicine.

Tatiana Foroud, Ph.D.
The central focus of research in Dr. Tatiana Foroud’s laboratory is the identification of genes contributing to disease. Ongoing studies are focusing on a variety of disorders including Parkinson disease, Alzheimer disease, intracranial aneurysms, alcohol dependence, and cancer. The tools that are currently being employed for gene identification include the genomewide association approach which evaluates millions of SNPs throughout the genome to identify relatively common variants contributing to disease susceptibility. Another approach being utilized with increasing frequency is sequencing – currently of the exome – to identify rare variants that have large effects on disease risk. Dr. Foroud’s research group utilizes statistical approaches to analyze the large amounts of data being generated.

Dr. Foroud is a Director, Division of Hereditary Genomics and a P. Michael Conneally Professor of Medical and Molecular Genetics at Indiana University and currently teaches two of the courses in the Hereditary Genomics Division. She received her Ph.D. from the Indiana University School of Medicine.

Want to hear more from Dr. Brooks? Catch him at the Biorepositories and Sample Management Conference.  Join us September 8-10 in Boston, MA. Download the agenda to see what’s on tap.

SAVE $100Register here and use code XP1998BLOG.

Follow us on Twitter
Like us on Facebook
Join us on LinkedIn




No comments: